Express Pharma - Page 847 of 2181 - Express Pharma

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

Bristol Myers Squibb clinches acquisition of Forbius

Samsung Biologics and AstraZeneca sign manufacturing deal for $330.8 million

Haryana showcases readiness to bid for bulk drugs and medical device parks at PHDCCI webinar

SPARC signs license agreement with Tripoint Therapeutics for Elepsia XR tablets

ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment

BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment

analytica Anacon India & India Lab Expo Hyderabad edition to be held in Sept, 2021

Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection

Developing herd immunity without pharma interventions may have detrimental consequences: Choubey

LSV Capital to invest $70 million for Indian healthcare, life sciences start-ups